Chad Therapeutics (CHADQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2003 | 03-2002 | 03-2001 | 03-2000 | 03-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -433 | 1,157 | -3,011 | -2,511 | -1,464 |
| Depreciation Amortization | 768 | 902 | 909 | 894 | 894 |
| Income taxes - deferred | N/A | N/A | N/A | 445 | -381 |
| Accounts receivable | -184 | 19 | -349 | 162 | 304 |
| Accounts payable and accrued liabilities | -36 | 312 | 151 | 87 | -503 |
| Other Working Capital | 308 | -2,206 | 1,779 | 3,055 | -457 |
| Other Operating Activity | 1,154 | -331 | 213 | -224 | 276 |
| Operating Cash Flow | $1,577 | $-147 | $-308 | $1,908 | $-1,331 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -243 | -397 | -255 | -123 | -194 |
| Other Investing Activity | -278 | 0 | -150 | -150 | 0 |
| Investing Cash Flow | $-521 | $-397 | $-405 | $-273 | $-194 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 20 | 5 | N/A | N/A | 187 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -104 |
| Financing Cash Flow | $20 | $5 | $N/A | $N/A | $83 |
| Beginning Cash Position | 520 | 1,059 | 1,772 | 137 | 1,579 |
| End Cash Position | 1,596 | 520 | 1,059 | 1,772 | 137 |
| Net Cash Flow | $1,076 | $-539 | $-713 | $1,635 | $-1,442 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,577 | -147 | -308 | 1,908 | -1,331 |
| Capital Expenditure | -243 | -398 | -266 | -123 | -194 |
| Free Cash Flow | 1,334 | -545 | -574 | 1,785 | -1,525 |